Lv51
1158 积分 2024-03-05 加入
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
10天前
已完结
Drug deconjugation-assisted peptide mapping by LC–MS/MS to identify conjugation sites and quantify site occupancy for antibody-drug conjugates
1个月前
已完结
Annual review of EGFR inhibitors in 2024
1个月前
已完结
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
1个月前
已完结
An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio
1个月前
已完结
Cancer Throughlines: 25 Years after First Approval, ADCs Continue to Pick up Steam
1个月前
已关闭
Hallmarks of Cancer: The Next Generation
1个月前
已完结
Non-small-cell lung cancer
2个月前
已完结
Current strategies for the discovery and bioconjugation of smaller, targetable drug conjugates tailored for solid tumor therapy
3个月前
已完结
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody–Drug conjugates
3个月前
已关闭
皖公网安备34019202002308
